
Our NeuroAccess™ device is being designed to enable liquid biopsy and improve drug delivery to the brain.
Design Goals
- Portable & Designed for the community clinic
- Non-Invasive & Painless
- Patient
- No hair shave, implant, or fixation necessary
- Outpatient visit duration of 30 min or less

Envisioned NeuroAccess Treatment Workflow
Pre-Treatment Planning
- The physician would identify the target region-of-interest (ROI) using diagnostic MRI or CT imaging.
- A patient-specific treatment plan would be generated and uploaded to the device.
- The Cordance Cap would be fitted to the patient using a disposable water jacket.
Envisioned Treatment Procedure
- Microbubbles would be administered into the circulating bloodstream.
- Low-frequency transducers on the Cordance Cap would focus ultrasound energy on the selected ROI.
- Sonication would cause microbubbles flowing through the ROI to vibrate
Intended Treatment Effects
- The treatment is intended to reversibly stretch the lining of blood vessels within the ROI.
- This temporary BBB opening is intended to allow large molecules to move across the BBB into and out of brain parenchyma.


Our development efforts are focused on the following
To enable precise BBB opening using NeuroAccess to unlock diagnostic and therapeutic brain disease markets

To enable liquid biopsy for real-time genomic characterization of brain disease to better diagnose and select therapy.


To enable precision-guided drug delivery to diseased brain regions.

Disclaimer: This product is currently in development and clinical safety and benefit still need to be established. This product has not received regulatory approval in any country and is not offered for sale.
All depictions of the NeuroAccess Device are for illustrative purposes only.